Join Paid Clinical Trials for Allergies World Wide

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Allergies

Top of Directory » All Categories » by Illness » Allergies



  • Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphysims

    Condition:   Acute Asthma
    Intervention:  
    Sponsors:   MetroHealth Medical Center;   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population

    Conditions:   Atopic Dermatitis;   Ichthyosis Vulgaris
    Intervention:  
    Sponsors:   Northwestern University;   IBT laboratories
    Not yet recruiting - verified November 2009
  • Effect of Veramyst and Olopadatine 0.2% Opthalmic Solution on Allergy Symptoms

    Condition:   Seasonal Allergic Rhinitis
    Interventions:   Drug: Veramyst /Artificial tears;   Drug: Veramyst / Artificial tears lubricant eye drops;   Drug: Veramyst nasal spray and Olopatadine eye drops;   Other: Veramyst placebo and Olopatadine0.2% eye drops
    Sponsors:   University of Chicago;   GlaxoSmithKline
    Recruiting - verified November 2009
  • The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism

    Conditions:   Rhinitis;   Urticaria
    Intervention:   Drug: levocetirizine or placebo
    Sponsors:   Wake Forest University;   UCB, Inc.
    Recruiting - verified November 2009
  • The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge

    Condition:   Cat Allergy
    Interventions:   Drug: Omalizumab;   Drug: Placebo
    Sponsors:   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID);   Genentech
    Recruiting - verified October 2009
  • Study of AHIST in Seasonal Allergic Rhinitis Patients

    Condition:   Rhinitis, Allergic, Seasonal
    Intervention:   Drug: AHIST NDC#58407-012-01
    Sponsor:   Magna Pharmaceuticals, Inc.
    Not yet recruiting - verified October 2009
  • A Community Health Worker Home Intervention to Improve Pediatric Asthma Outcomes

    Condition:   Asthma
    Intervention:   Behavioral: Wee Wheezers
    Sponsors:   Montefiore Medical Center;   American Lung Association
    Recruiting - verified October 2009
  • AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation

    Condition:   Allergic Conjunctivitis Associated Inflammation
    Interventions:   Drug: AL-38583 Ophthalmic Solution;   Drug: AL-38583 Ophthalmic Solution Vehicle;   Drug: Dexamethasone Ophthalmic Suspension
    Sponsors:   Alcon Research;   Ophthalmic Research Associates, Inc
    Not yet recruiting - verified October 2009
  • Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

    Condition:   Asthma
    Intervention:   Biological: Mepolizumab (treatment) - Severe asthma
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Moderate to Persistent Asthma in the Obese Subject

    Condition:   Asthma
    Interventions:   Drug: Montelukast;   Other: Sugar pill
    Sponsor:   Duke University
    Not yet recruiting - verified November 2009
  • A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

    Conditions:   Severe, Refractory Asthma;   Airway Inflammation;   Airflow Obstruction
    Intervention:   Drug: Pioglitazone
    Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting - verified September 2009
  • Sugammadex Hypersensitivity Study (Study P06042)

    Condition:   Hypersensitivity
    Interventions:   Drug: Sugammadex 4 mg/kg;   Drug: Sugammadex 16 mg/kg;   Drug: Placebo
    Sponsor:   Schering-Plough
    Recruiting - verified October 2009
  • Long Term Safety and Efficacy Trial of Budesonide Dipropionate - Hydroflouroalkane (BDP-HFA) 320 Mcg in Allergic Rhinitis

    Condition:   Rhinitis, Allergic, Perennial
    Interventions:   Drug: BDP;   Drug: Placebo
    Sponsor:   Teva Global Respiratory Research LLC
    Recruiting - verified October 2009
  • Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma

    Condition:   Asthma
    Interventions:   Drug: ABT-308;   Drug: ABT-308;   Drug: Placebo;   Drug: Placebo
    Sponsor:   Abbott
    Recruiting - verified October 2009
  • A Study of the Safety and Efficacy of JNJ-39758979 in the Treatment of Adults With Asthma

    Condition:   Asthma
    Intervention:   Drug: JNJ39758979
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009
  • AZD2066 Neuropathic Pain - Mechanical Hypersensitivity

    Conditions:   Neuropathic Pain;   Mechanical Hypersensitivity
    Interventions:   Drug: AZD2066;   Drug: Placebo
    Sponsors:   AstraZeneca;   Quintiles
    Recruiting - verified November 2009
  • Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

    Condition:   Asthma
    Interventions:   Drug: QMF149 Twisthaler®;   Drug: Mometasone Twisthaler®
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified November 2009
  • Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers

    Conditions:   HIV;   Asthma
    Interventions:   Drug: Darunavir;   Drug: Ritonavir;   Drug: Beclomethasone Dipropionate HFA
    Sponsor:   National Institutes of Health Clinical Center (CC)
    Recruiting - verified July 2009
  • A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids

    Condition:   Asthma
    Interventions:   Drug: lebrikizumab (MILR1444A);   Drug: placebo
    Sponsor:   Genentech
    Recruiting - verified October 2009
  • A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

    Condition:   Hereditary Angioedema
    Interventions:   Drug: Icatibant;   Drug: Placebo
    Sponsors:   Jerini AG;   Shire Human Genetic Therapies, Inc.
    Recruiting - verified November 2009
  • A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis

    Conditions:   Anaphylaxis;   Hypotension;   Bronchospasm;   Angioedema
    Interventions:   Drug: Epinephrine;   Procedure: Bone Marrow Apsiration;   Drug: Omalizumab (Xolair)
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified April 2009
  • Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis

    Conditions:   Psoriasis;   Atopic Dermatitis;   Healthy Dermatology Patients
    Intervention:   Other: Vital signs, height, weight, body mass index (BMI) calculation, waist circumference.
    Sponsor:   Northwestern University
    Recruiting - verified November 2009
  • Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose

    Condition:   Allergic Airway Disease
    Intervention:   Drug: Broccoli sprout extract
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified May 2009
  • Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults

    Conditions:   Food Hypersensitivity;   Hypersensitivity;   Immediate Hypersensitivity;   Peanut Hypersensitivity
    Intervention:   Biological: E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Allertein Therapeutics, LLC;   Consortium of Food Allergy Research
    Recruiting - verified January 2009
  • Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma

    Condition:   Asthma
    Interventions:   Drug: Active GSK679586;   Drug: Placebo
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin

    Conditions:   Colorectal Cancer;   Esophageal Cancer;   Gastric Cancer;   Small Bowel Cancer;   Pancreatic Cancer
    Intervention:  
    Sponsors:   Dana-Farber Cancer Institute;   Sanofi-Aventis
    Recruiting - verified October 2009
  • A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

    Condition:   Asthma
    Interventions:   Drug: Levalbuterol;   Drug: Levalbuterol UDV TID;   Drug: Placebo
    Sponsor:   Sepracor, Inc.
    Recruiting - verified October 2009
  • Normal Blood, Bone Marrow and Buccal Mucosa Protocol

    Condition:   Healthy
    Intervention:  
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified October 2009
  • Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

    Condition:   Perennial Allergic Rhinitis
    Interventions:   Drug: PATANASE nasal spray;   Drug: Olopatadine Nasal Spray vehicle
    Sponsor:   Alcon Research
    Recruiting - verified November 2009
  • A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered MEDI-563

    Condition:   Asthma
    Interventions:   Biological: MEDI-563;   Biological: MEDI-563;   Other: Placebo
    Sponsor:   MedImmune LLC
    Recruiting - verified October 2009
  • Safety Study of AMG 157 in Healthy Subjects and Subjects With Atopic Dermatitis

    Conditions:   Atopic Dermatitis;   Healthy Volunteers
    Intervention:   Drug: AMG 157
    Sponsor:   Amgen
    Recruiting - verified November 2009
  • MethaCholine Bronchoprovocation Study (MeCIS)

    Condition:   Asthma
    Intervention:   Drug: fluticasone diskus
    Sponsors:   Johns Hopkins Bloomberg School of Public Health;   Washington University School of Medicine;   St. Louis University;   Long Island Jewish Medical Center;   North Shore University Hospital;   Baylor College of Medicine;   University of Vermont;   Nemours Children's Clinic;   University of Florida;   Indiana University;   Ohio State University;   New York University School of Medicine;   University of Missouri-Columbia;   Northwestern University;   Louisiana State University;   University of Miami;   University of South Florida;   University of California, San Diego;   National Jewish Health;   Duke University
    Recruiting - verified October 2009
  • Biomarkers in Exhaled Breath From Asthmatic Patients

    Condition:   Asthma
    Intervention:  
    Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting - verified February 2009
  • 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

    Condition:   Atopic Dermatitis
    Intervention:   Drug: Pimecrolimus
    Sponsors:   Novartis;   Clinical Research Computing Unit (University of Pennsylvania)
    Recruiting - verified November 2009
  • Use of High Frequency Chest Compression in Pediatric Status Asthmaticus

    Condition:   Status Asthmaticus, Pediatric
    Intervention:   Device: High Frequency Chest Compression VEST
    Sponsor:   Texas Tech University Health Sciences Center
    Recruiting - verified October 2009
  • Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia

    Condition:   Leukemia
    Intervention:   Drug: asparaginase-Erwinia
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009
  • Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)

    Condition:   Rhinitis, Allergic, Perennial
    Interventions:   Drug: triamcinolone acetonide;   Other: placebo
    Sponsor:   Sanofi-Aventis
    Recruiting - verified October 2009
  • Sample Collections From the Airways of Asthmatic Patients

    Conditions:   Asthma;   Healthy
    Intervention:  
    Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting - verified November 2009
    • Menu
    Find Paid Clinical Trials